Literature DB >> 19908873

Multiobjective optimization of pharmacophore hypotheses: bias toward low-energy conformations.

Eleanor J Gardiner1, David A Cosgrove, Robin Taylor, Valerie J Gillet.   

Abstract

Two methods are described for biasing conformational search during pharmacophore elucidation using a multiobjective genetic algorithm (MOGA). The MOGA explores conformation on-the-fly while simultaneously aligning a set of molecules such that their pharmacophoric features are maximally overlaid. By using a clique detection method to generate overlays of precomputed conformations to initialize the population (rather than starting from random), the speed of the algorithm has been increased by 2 orders of magnitude. This increase in speed has enabled the program to be applied to greater numbers of molecules than was previously possible. Furthermore, it was found that biasing the conformations explored during search time to those found in the Cambridge Structural Database could also improve the quality of the results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19908873     DOI: 10.1021/ci9002816

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  4 in total

1.  Development and validation of an improved algorithm for overlaying flexible molecules.

Authors:  Robin Taylor; Jason C Cole; David A Cosgrove; Eleanor J Gardiner; Valerie J Gillet; Oliver Korb
Journal:  J Comput Aided Mol Des       Date:  2012-04-27       Impact factor: 3.686

2.  MolAlign: an algorithm for aligning multiple small molecules.

Authors:  Shek Ling Chan
Journal:  J Comput Aided Mol Des       Date:  2017-06-01       Impact factor: 3.686

3.  Training a scoring function for the alignment of small molecules.

Authors:  Shek Ling Chan; Paul Labute
Journal:  J Chem Inf Model       Date:  2010-09-27       Impact factor: 4.956

4.  Pharmacophore-based similarity scoring for DOCK.

Authors:  Lingling Jiang; Robert C Rizzo
Journal:  J Phys Chem B       Date:  2014-10-10       Impact factor: 2.991

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.